Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 - United States, January-February 2020

Rachel M Burke, Claire M Midgley, Alissa Dratch, Marty Fenstersheib, Thomas Haupt, Michelle Holshue, Isaac Ghinai, M Claire Jarashow, Jennifer Lo, Tristan D McPherson, Sara Rudman, Sarah Scott, Aron J Hall, Alicia M Fry, Melissa A Rolfes, Rachel M Burke, Claire M Midgley, Alissa Dratch, Marty Fenstersheib, Thomas Haupt, Michelle Holshue, Isaac Ghinai, M Claire Jarashow, Jennifer Lo, Tristan D McPherson, Sara Rudman, Sarah Scott, Aron J Hall, Alicia M Fry, Melissa A Rolfes

Abstract

In December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by the virus SARS-CoV-2, began in Wuhan, China (1). The disease spread widely in China, and, as of February 26, 2020, COVID-19 cases had been identified in 36 other countries and territories, including the United States. Person-to-person transmission has been widely documented, and a limited number of countries have reported sustained person-to-person spread.* On January 20, state and local health departments in the United States, in collaboration with teams deployed from CDC, began identifying and monitoring all persons considered to have had close contact† with patients with confirmed COVID-19 (2). The aims of these efforts were to ensure rapid evaluation and care of patients, limit further transmission, and better understand risk factors for transmission.

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

References

    1. Coronavirus disease. 2019. (COVID-19): situation report – 36. Geneva, Switzerland: World Health Organization; 2020.
    1. Patel A, Jernigan DB; 2019-nCoV CDC Response Team. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak—United States, December 31, 2019–February 4, 2020. MMWR Morb Mortal Wkly Rep 2020;69:140–6. 10.15585/mmwr.mm6905e1

Source: PubMed

3
Abonnere